Contact
searchSearch
HMP Global

HIV PrEP

Featured Article

Study Finds Rising PrEP Use and Declining Costs Amid Shift to Generics
04/02/2025
Grace Taylor, MS, MA
A recent study shows rising pre-exposure prophylaxis (PrEP) utilization and declining costs as generic formulations replace branded versions in HIV prevention.
A recent study shows rising pre-exposure prophylaxis (PrEP) utilization and declining costs as generic formulations replace branded versions in HIV prevention.
A recent study shows rising...
04/02/2025
First Report Managed Care
News
HIV Cases Rise Among Gay Latinos
07/24/2024
Grace Taylor, MS, MA
As HIV rates continue to rise among Latino gay and bisexual men, health policy advocates stress the need for more federal assistance for HIV treatment and prevention in this community.
As HIV rates continue to rise among Latino gay and bisexual men, health policy advocates stress the need for more federal assistance for HIV treatment and prevention in this community.
As HIV rates continue to rise...
07/24/2024
First Report Managed Care
News
Injectable PrEP Overall Acceptable, Preferred for HIV Prevention
07/15/2023
Maria Asimopoulos
“Given overall acceptability, injectable PrEP should be included as part of a menu of prevention options, allowing end-users to select the modality that suits their preferences, needs and lifestyle,” researchers advised.
“Given overall acceptability, injectable PrEP should be included as part of a menu of prevention options, allowing end-users to select the modality that suits their preferences, needs and lifestyle,” researchers advised.
“Given overall acceptability,...
07/15/2023
First Report Managed Care
News
Study Estimates Billable Per Patient Costs of Providing PrEP
12/20/2022
Jolynn Tumolo
Researchers used clinic billing records in Washington, DC and Chicago to estimate the annual billable costs associated with the use of preexposure prophylaxis for HIV.
Researchers used clinic billing records in Washington, DC and Chicago to estimate the annual billable costs associated with the use of preexposure prophylaxis for HIV.
Researchers used clinic billing...
12/20/2022
First Report Managed Care
News
Women View PrEP Services as a Natural Extension of OB/GYN Care
11/17/2022
Jolynn Tumolo
“Multiple participants suggested that initial counseling on PrEP should be offered universally to patients, regardless of sexual history or personal risk factors,” researchers advised.
“Multiple participants suggested that initial counseling on PrEP should be offered universally to patients, regardless of sexual history or personal risk factors,” researchers advised.
“Multiple participants suggested...
11/17/2022
First Report Managed Care
News
Black Sexual Minority Men Report Higher Prevalence of PrEP Use Than White Men
11/14/2022
Jolynn Tumolo
Investigators conducted a survey to determine how prevalent the use of pre- and post-exposure prophylaxis was among over 63,000 participants.
Investigators conducted a survey to determine how prevalent the use of pre- and post-exposure prophylaxis was among over 63,000 participants.
Investigators conducted a survey...
11/14/2022
First Report Managed Care
News
PrEP Most Effective for Reducing HIV Incidence in Men Who Have Sex With Men
11/07/2022
Jolynn Tumolo
Among a variety of interventions, pre-exposure prophylaxis was the only method that showed consistent effectiveness in reducing the incidence of HIV, new findings show.
Among a variety of interventions, pre-exposure prophylaxis was the only method that showed consistent effectiveness in reducing the incidence of HIV, new findings show.
Among a variety of...
11/07/2022
First Report Managed Care
News
Positive Sources of PrEP Awareness Include Partners, Peers, Health Promotions
09/27/2022
Jolynn Tumolo
"Messages from health campaigns were perceived as most positive, and those from religious institutions as least positive," authors said.
"Messages from health campaigns were perceived as most positive, and those from religious institutions as least positive," authors said.
"Messages from health campaigns...
09/27/2022
First Report Managed Care
News
Monitoring HIV Strains to Prevent PrEP Failure, Viral Transmission
09/09/2022
Jolynn Tumolo
Study authors employed a strategy to monitor populations for HIV strains that are resistant to tenofovir and emtricitabine and ensure PrEP failure rates remain rare.
Study authors employed a strategy to monitor populations for HIV strains that are resistant to tenofovir and emtricitabine and ensure PrEP failure rates remain rare.
Study authors employed a...
09/09/2022
First Report Managed Care
News
High Distress in Black MSM Lowers Odds of Antiretroviral Therapy Adherence
09/02/2022
Jolynn Tumolo
High rates of psychological distress may represent an important barrier against HIV treatment adherence for Black men who have sex with men living in urban areas, researchers said.
High rates of psychological distress may represent an important barrier against HIV treatment adherence for Black men who have sex with men living in urban areas, researchers said.
High rates of psychological...
09/02/2022
First Report Managed Care
News
Social Support Affects PrEP Use in Black Sexual Minority Individuals Experiencing Discrimination
07/29/2022
Jolynn Tumolo
"While our findings showed some unanticipated relationships, they provide insight into how discrimination and stigma may influence PrEP use and disparities," researchers said.
"While our findings showed some unanticipated relationships, they provide insight into how discrimination and stigma may influence PrEP use and disparities," researchers said.
"While our findings showed some...
07/29/2022
First Report Managed Care

Newsfeed

News
HIV Cases Rise Among Gay Latinos
07/24/2024
Grace Taylor, MS, MA
As HIV rates continue to rise among Latino gay and bisexual men, health policy advocates stress the need for more federal assistance for HIV treatment and prevention in this community.
As HIV rates continue to rise among Latino gay and bisexual men, health policy advocates stress the need for more federal assistance for HIV treatment and prevention in this community.
As HIV rates continue to rise...
07/24/2024
First Report Managed Care
News
Injectable PrEP Overall Acceptable, Preferred for HIV Prevention
07/15/2023
Maria Asimopoulos
“Given overall acceptability, injectable PrEP should be included as part of a menu of prevention options, allowing end-users to select the modality that suits their preferences, needs and lifestyle,” researchers advised.
“Given overall acceptability, injectable PrEP should be included as part of a menu of prevention options, allowing end-users to select the modality that suits their preferences, needs and lifestyle,” researchers advised.
“Given overall acceptability,...
07/15/2023
First Report Managed Care
News
Study Estimates Billable Per Patient Costs of Providing PrEP
12/20/2022
Jolynn Tumolo
Researchers used clinic billing records in Washington, DC and Chicago to estimate the annual billable costs associated with the use of preexposure prophylaxis for HIV.
Researchers used clinic billing records in Washington, DC and Chicago to estimate the annual billable costs associated with the use of preexposure prophylaxis for HIV.
Researchers used clinic billing...
12/20/2022
First Report Managed Care
News
Women View PrEP Services as a Natural Extension of OB/GYN Care
11/17/2022
Jolynn Tumolo
“Multiple participants suggested that initial counseling on PrEP should be offered universally to patients, regardless of sexual history or personal risk factors,” researchers advised.
“Multiple participants suggested that initial counseling on PrEP should be offered universally to patients, regardless of sexual history or personal risk factors,” researchers advised.
“Multiple participants suggested...
11/17/2022
First Report Managed Care
News
Black Sexual Minority Men Report Higher Prevalence of PrEP Use Than White Men
11/14/2022
Jolynn Tumolo
Investigators conducted a survey to determine how prevalent the use of pre- and post-exposure prophylaxis was among over 63,000 participants.
Investigators conducted a survey to determine how prevalent the use of pre- and post-exposure prophylaxis was among over 63,000 participants.
Investigators conducted a survey...
11/14/2022
First Report Managed Care
News
PrEP Most Effective for Reducing HIV Incidence in Men Who Have Sex With Men
11/07/2022
Jolynn Tumolo
Among a variety of interventions, pre-exposure prophylaxis was the only method that showed consistent effectiveness in reducing the incidence of HIV, new findings show.
Among a variety of interventions, pre-exposure prophylaxis was the only method that showed consistent effectiveness in reducing the incidence of HIV, new findings show.
Among a variety of...
11/07/2022
First Report Managed Care
News
Positive Sources of PrEP Awareness Include Partners, Peers, Health Promotions
09/27/2022
Jolynn Tumolo
"Messages from health campaigns were perceived as most positive, and those from religious institutions as least positive," authors said.
"Messages from health campaigns were perceived as most positive, and those from religious institutions as least positive," authors said.
"Messages from health campaigns...
09/27/2022
First Report Managed Care
News
Monitoring HIV Strains to Prevent PrEP Failure, Viral Transmission
09/09/2022
Jolynn Tumolo
Study authors employed a strategy to monitor populations for HIV strains that are resistant to tenofovir and emtricitabine and ensure PrEP failure rates remain rare.
Study authors employed a strategy to monitor populations for HIV strains that are resistant to tenofovir and emtricitabine and ensure PrEP failure rates remain rare.
Study authors employed a...
09/09/2022
First Report Managed Care
News
High Distress in Black MSM Lowers Odds of Antiretroviral Therapy Adherence
09/02/2022
Jolynn Tumolo
High rates of psychological distress may represent an important barrier against HIV treatment adherence for Black men who have sex with men living in urban areas, researchers said.
High rates of psychological distress may represent an important barrier against HIV treatment adherence for Black men who have sex with men living in urban areas, researchers said.
High rates of psychological...
09/02/2022
First Report Managed Care
News
Social Support Affects PrEP Use in Black Sexual Minority Individuals Experiencing Discrimination
07/29/2022
Jolynn Tumolo
"While our findings showed some unanticipated relationships, they provide insight into how discrimination and stigma may influence PrEP use and disparities," researchers said.
"While our findings showed some unanticipated relationships, they provide insight into how discrimination and stigma may influence PrEP use and disparities," researchers said.
"While our findings showed some...
07/29/2022
First Report Managed Care
News
Autoimmune Disease Impact on Health and Productivity of US Employees
03/26/2025
Grace Taylor, MS, MA
Chronic autoimmune conditions are emerging as a major, underrecognized burden on employers, driving up health care costs and disability claims across the US workforce.
Chronic autoimmune conditions are emerging as a major, underrecognized burden on employers, driving up health care costs and disability claims across the US workforce.
Chronic autoimmune conditions...
03/26/2025
First Report Managed Care
News
Initiating Cariprazine as First Adjunctive Therapy Linked to Lower Mental Health Costs in MDD
03/25/2025
Hannah Musick
Initiating cariprazine as the first adjunctive therapy in major depressive disorder (MDD) is associated with significantly lower mental health-related health care utilization and costs compared to using it after other adjunctive treatments.
Initiating cariprazine as the first adjunctive therapy in major depressive disorder (MDD) is associated with significantly lower mental health-related health care utilization and costs compared to using it after other adjunctive treatments.
Initiating cariprazine as the...
03/25/2025
First Report Managed Care
News
Study Flags Risk of Selection Bias in Evaluating Medicaid Health Plans
03/24/2025
Hannah Musick
A new study reveals that selection bias, not plan performance, may drive observed racial disparities in Medicaid care, challenging the validity of using these metrics for payment or public reporting.
A new study reveals that selection bias, not plan performance, may drive observed racial disparities in Medicaid care, challenging the validity of using these metrics for payment or public reporting.
A new study reveals that...
03/24/2025
First Report Managed Care
News
Emerging Treatments Improve Outcomes for Patients With Relapsed/Refractory Follicular Lymphoma
03/21/2025
Lisa Kuhns, PhD, MD
Recent advancements in bispecific antibodies (BsAbs) and chimeric antigen receptor (CAR) T-cell therapies are revolutionizing the treatment landscape for patients with relapsed or refractory follicular lymphoma (RR-FL), offering new hope for...
Recent advancements in bispecific antibodies (BsAbs) and chimeric antigen receptor (CAR) T-cell therapies are revolutionizing the treatment landscape for patients with relapsed or refractory follicular lymphoma (RR-FL), offering new hope for...
Recent advancements in...
03/21/2025
First Report Managed Care
News
Biosimilars Gain Market Traction but Adoption Varies by Demographics and Other Factors
03/18/2025
Grace Taylor, MS, MA
Biosimilars are gaining market share and reducing drug costs, but patient adoption varies based on demographics, care settings, and payer policies.
Biosimilars are gaining market share and reducing drug costs, but patient adoption varies based on demographics, care settings, and payer policies.
Biosimilars are gaining market...
03/18/2025
First Report Managed Care
News
Patients With Vitiligo Face Elevated Risk of Cardiovascular Disease, Study Finds
03/14/2025
Grace Taylor, MS, MA
Individuals with vitiligo have an increased risk of major cardiovascular events, including stroke and venous thromboembolism, according to researchers.
Individuals with vitiligo have an increased risk of major cardiovascular events, including stroke and venous thromboembolism, according to researchers.
Individuals with vitiligo have...
03/14/2025
First Report Managed Care
News
Unlocking Cost-Efficiency and Access With Biosimilar Bevacizumab in Medicare
03/13/2025
Hannah Musick
New research shows significant cost savings and potential for expanded access to biosimilar bevacizumab in Medicare for patients with metastatic colorectal and non-small cell lung cancer.
New research shows significant cost savings and potential for expanded access to biosimilar bevacizumab in Medicare for patients with metastatic colorectal and non-small cell lung cancer.
New research shows significant...
03/13/2025
First Report Managed Care
News
Study Finds Limited Benefit of Common MS Fatigue Medications
03/12/2025
Grace Taylor, MS, MA
Commonly used medications for multiple sclerosis-related fatigue offer minimal clinical benefit and are more likely to cause treatment discontinuation due to side effects, according to a systematic review and meta-analysis published in...
Commonly used medications for multiple sclerosis-related fatigue offer minimal clinical benefit and are more likely to cause treatment discontinuation due to side effects, according to a systematic review and meta-analysis published in...
Commonly used medications for...
03/12/2025
First Report Managed Care
News
Bridging the Gap: Mental Health Support for Individuals With Skin Conditions
03/07/2025
Hannah Musick
A recently published review explores the impact of skin diseases on mental health, emphasizing the need for culturally sensitive approaches and digital health technologies to support individuals with skin conditions.
A recently published review explores the impact of skin diseases on mental health, emphasizing the need for culturally sensitive approaches and digital health technologies to support individuals with skin conditions.
A recently published review...
03/07/2025
First Report Managed Care
News
Bispecific Antibody Therapy Achieves Sustained Remissions in Follicular Lymphoma
03/06/2025
Juliet Gallagher
A 3-year follow-up of a phase 1/2 study confirms that mosunetuzumab, a CD20×CD3 bispecific antibody, provides durable remissions, high response rates, and a favorable safety profile in relapsed or refractory follicular lymphoma, reinforcing...
A 3-year follow-up of a phase 1/2 study confirms that mosunetuzumab, a CD20×CD3 bispecific antibody, provides durable remissions, high response rates, and a favorable safety profile in relapsed or refractory follicular lymphoma, reinforcing...
A 3-year follow-up of a phase...
03/06/2025
First Report Managed Care

Insights

Headshot of Brian Mustanski, Northwestern University
Interview
Insurance Coverage, Relationship Status, Other Factors Linked to PrEP Reinitiation
04/14/2022
Maria Asimopoulos
Brian Mustanski, PhD, professor of medical social sciences, Northwestern University, shares factors influencing whether patients reinitiate preexposure prophylaxis for HIV after discontinuation.
Brian Mustanski, PhD, professor of medical social sciences, Northwestern University, shares factors influencing whether patients reinitiate preexposure prophylaxis for HIV after discontinuation.
Brian Mustanski, PhD, professor...
04/14/2022
First Report Managed Care
Chris Beyrer
Podcasts
PrEP in the United States Faces Slow Uptake and Coverage Among Payers
06/30/2021
Julie Gould
Chris Beyrer, MD, infectious disease epidemiologist and professor at Johns Hopkins Bloomberg School of Public Health, breaks down current rates of HIV across the United States as well as the challenges linked with controlling this...
Chris Beyrer, MD, infectious disease epidemiologist and professor at Johns Hopkins Bloomberg School of Public Health, breaks down current rates of HIV across the United States as well as the challenges linked with controlling this...
Chris Beyrer, MD, infectious...
06/30/2021
First Report Managed Care
Addressing Barriers to Preventive HIV Care for At-Risk Patient Populations
Podcasts
Addressing Barriers to Preventive HIV Care for At-Risk Patient Populations
01/25/2021
Ed Pezalla, MD, CEO, Enlightenment Bioconsult LLC, speaks about the barriers to preventive HIV care, pinpoints how payers can reach at-risk populations, and reviews the US Preventive Services Task Force’s measures requiring health plans to...
Ed Pezalla, MD, CEO, Enlightenment Bioconsult LLC, speaks about the barriers to preventive HIV care, pinpoints how payers can reach at-risk populations, and reviews the US Preventive Services Task Force’s measures requiring health plans to...
Ed Pezalla, MD, CEO,...
01/25/2021
First Report Managed Care
Examining a New Class of Antiretroviral Therapy for Patients With Multidrug-Resistant HIV-1 Infection
Videos
Examining a New Class of Antiretroviral Therapy for Patients With Multidrug-Resistant HIV-1 Infection
09/23/2020
Max Lataillade, DO, head of global research strategy, ViiV Healthcare, discusses the findings of the BRIGHTE study that demonstrated a significant decrease in HIV-1 RNA levels among patients treated with fostemsavir, a first-in-class...
Max Lataillade, DO, head of global research strategy, ViiV Healthcare, discusses the findings of the BRIGHTE study that demonstrated a significant decrease in HIV-1 RNA levels among patients treated with fostemsavir, a first-in-class...
Max Lataillade, DO, head of...
09/23/2020
First Report Managed Care

Related Content

FRMC Volume 22, Issue 1

Current Issue

March 2025
Volume 22
Issue 1
Current Issue
Issue Archive

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use